Cécile Martias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cécile Martias has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Antoine Lefèvre
UMR 1253, iBrain, University of Tours, Inserm, 37044 Tours, France
1 shared publication - Antoine Presset
Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253
1 shared publication - Camille Dupuy
Imaging Brain & Neuropsychiatry iBrain U1253, Université de Tours, INSERM, 37032 Tours, France
1 shared publication - John R. Hawse
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA
1 shared publication - Lydie Nadal-Desbarats
Imaging Brain & Neuropsychiatry iBrain U1253, Université de Tours, INSERM, 37032 Tours, France
1 shared publication - Malayannan Subramaniam
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA
1 shared publication
Latest Publications
- Open Access
- 17 June 2022
- Published by MDPI AG in Metabolites
- Vol. 12 (6) , 556
Serum and Soleus Metabolomics Signature of Klf10 Knockout Mice to Identify Potential Biomarkers
The transcription factor Krüppel-like factor 10 (Klf10), also known as Tieg1 for TGFβ (Inducible Early Gene-1) is known to control numerous genes in many cell types that are involved in various key biological processes (differentiation, proliferation, apoptosis, inflammation), including cell metabolism and human disease. In skeletal muscle, particularly in the soleus, deletion of the Klf10 gene (Klf10 KO) resulted in ultrastructure fiber disorganization and mitochondrial metabolism deficiencies, characterized by muscular hypertrophy. To determine the metabolic profile related to loss of Klf10 expression, we analyzed blood and soleus tissue using UHPLC-Mass Spectrometry. Metabolomics analyses on both serum and soleus revealed profound differences between wild-type (WT) and KO animals. Klf10 deficient mice exhibited alterations in metabolites associated with energetic metabolism. Additionally, chemical classes of aromatic and amino-acid compounds were disrupted, together with Krebs cycle intermediates, lipids and phospholipids. From variable importance in projection (VIP) analyses, the Warburg effect, citric acid cycle, gluconeogenesis and transfer of acetyl groups into mitochondria appeared to be possible pathways involved in the metabolic alterations observed in Klf10 KO mice. These studies have revealed essential roles for Klf10 in regulating multiple metabolic pathways whose alterations may underlie the observed skeletal muscle defects as well as other diseases.
- 17 June 2022
- Published by MDPI AG in Metabolites
- Vol. 12 (6) , 556
Open AccessSerum and Soleus Metabolomics Signature of Klf10 Knockout Mice to Identify Potential Biomarkers
The transcription factor Krüppel-like factor 10 (Klf10), also known as Tieg1 for TGFβ (Inducible Early Gene-1) is known to control numerous genes in many cell types that are involved in various key biological processes (differentiation, proliferation, apoptosis, inflammation), including cell metabolism and human disease. In skeletal muscle, particularly in the soleus, deletion of the Klf10 gene (Klf10 KO) resulted in ultrastructure fiber disorganization and mitochondrial metabolism deficiencies, characterized by muscular hypertrophy. To determine the metabolic profile related to loss of Klf10 expression, we analyzed blood and soleus tissue using UHPLC-Mass Spectrometry. Metabolomics analyses on both serum and soleus revealed profound differences between wild-type (WT) and KO animals. Klf10 deficient mice exhibited alterations in metabolites associated with energetic metabolism. Additionally, chemical classes of aromatic and amino-acid compounds were disrupted, together with Krebs cycle intermediates, lipids and phospholipids. From variable importance in projection (VIP) analyses, the Warburg effect, citric acid cycle, gluconeogenesis and transfer of acetyl groups into mitochondria appeared to be possible pathways involved in the metabolic alterations observed in Klf10 KO mice. These studies have revealed essential roles for Klf10 in regulating multiple metabolic pathways whose alterations may underlie the observed skeletal muscle defects as well as other diseases.